Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
Blood Cancer J. 2023 Dec 18;13(1):188. doi: 10.1038/s41408-023-00962-z.
Blood Cancer J. 2023.
PMID: 38110349
Free PMC article.
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
Van der Vreken A, Oudaert I, Ates G, Faict S, Vlummens P, Satilmis H, Fan R, Maes A, Massie A, De Veirman K, De Bruyne E, Vanderkerken K, Menu E.
Van der Vreken A, et al. Among authors: satilmis h.
J Pathol. 2023 Jun;260(2):112-123. doi: 10.1002/path.6066. Epub 2023 Mar 28.
J Pathol. 2023.
PMID: 36807305
Item in Clipboard
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.
Fan R, Satilmis H, Vandewalle N, Verheye E, Vlummens P, Maes A, Muylaert C, De Bruyne E, Menu E, Evans H, Chantry A, De Beule N, Hose D, Törngren M, Eriksson H, Vanderkerken K, Maes K, Breckpot K, De Veirman K.
Fan R, et al. Among authors: satilmis h.
J Immunother Cancer. 2023 Jan;11(1):e005319. doi: 10.1136/jitc-2022-005319.
J Immunother Cancer. 2023.
PMID: 36650020
Free PMC article.
Item in Clipboard
Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
Satilmis H, Verheye E, Vlummens P, Oudaert I, Vandewalle N, Fan R, Knight JM, De Beule N, Ates G, Massie A, Moreaux J, Maes A, De Bruyne E, Vanderkerken K, Menu E, Sloan EK, De Veirman K.
Satilmis H, et al.
J Pathol. 2023 Jan;259(1):69-80. doi: 10.1002/path.6020. Epub 2022 Nov 22.
J Pathol. 2023.
PMID: 36245401
Free PMC article.
Item in Clipboard
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
Oudaert I, Satilmis H, Vlummens P, De Brouwer W, Maes A, Hose D, De Bruyne E, Ghesquière B, Vanderkerken K, De Veirman K, Menu E.
Oudaert I, et al. Among authors: satilmis h.
J Exp Clin Cancer Res. 2022 Feb 1;41(1):45. doi: 10.1186/s13046-022-02250-3.
J Exp Clin Cancer Res. 2022.
PMID: 35105345
Free PMC article.
Item in Clipboard
Cite
Cite